ServiziMenu principaleHome
You are here: Home > Education > Future Events > 7th ESO Arab and Southern European Countries Masterclass in Clinical Oncology


Chairs: M.S. Aapro, CH - N. Pavlidis, GR
Co-chairs: J. Gligorov, FR - S. Khatib, JO
Host Chair: D. Papamichael, CY

This clinically oriented educational programme has been designed for medical and clinicaloncologists who wish to improve their skills in the management of cancer patients.
The programme will expose participants to a full spectrum of issues in clinical oncology and to practice-orientated training. The programme focuses on breast , gynaecological, lung, urologicaland gastrointestinal cancers. Spotlight sessions will facilitate compact update on head and neck, melanoma, elderly patients, soft tissue sarcoma, non-Hodgkin lymphoma.

The Masterclass offers plenary lectures discussing current issues and controversies as well as critically reviewing significant therapeutic developments. State-of-the-art data recognized by ESMO and other evidence-based guidelines will be cited. Participants will deliver casepresentations within tumour boards and discuss them with the chairs and the faculty.
All participants will reside at the course venue and participation is compulsory throughout the course. The Masterclass will be entirely in English and at least an intermediate level of English is necessary for admission.

• Full immersion
• Clinically-oriented
• Multidisciplinary
• An international faculty of top experts delivering lectures focusing on breast , gynaecological, lung, urological and gastrointestinal cancers.

Held under the auspices of the           


FACULTY (as of April 2018)
M.S. Aapro, Clinique de Genolier, CH
D. Arnold, CUF Hospitals Cancer Center, Lisbon, PT
H. Azim, Cairo University, Cairo Oncology Center, EG
H. Azim jr, American University of Beirut, LB
M.J. Cardoso, Champalimaud Foundation, Lisbon, PT
G. Ceresoli, Humanitas Gavazzeni, Bergamo, IT
A. Constantinidou, University of Cyprus, Medical School, Nicosia, CY
G. Curigliano, European Institute of Oncology, Milan, IT
A. Eggermont, Institut Gustave Roussy, Paris, FR
R. Gaafar, National Cancer Institute, Cairo, EG
F. Geara, American University of Beirut, LB
J. Gligorov, APHP Tenon, IUC-UPMC, Sorbonne University, Paris, FR
J. Khader, King Hussein Cancer Center, Amman, JO
H. Khaled, National Cancer Institute, Cairo, EG
S. Khatib, Arab Medical Association Against Cancer (AMAAC), Amman, JO
N. Mottet, University Jean Monnet, Saint Etienne, FR
R. Orecchia, European Institute of Oncology, Milan, IT
O. Pagani, Oncology Institute of Southern Switzerland (IOSI), Bellinzona, CH
D. Papamichael, Bank of Cyprus Oncology Centre, Nicosia, CY
N. Pavlidis, Ioannina School of Medicine, GR
G. Pruneri, National Cancer Institute, Milan, IT
J. Remon-Masip, Hospital Vall'd'Hebron, Barcelona, ES
A. Shamseddine, American University of Beirut, LB
A. Stathis, Oncology Institute of Southern Switzerland (IOSI), Bellinzona, CH
J.B. Vermorken, Antwerp University Hospital, BE

General information

Daniela Mengato
European School of Oncology (ESO)
Via Turati 29 - 20121 Milan, Italy
Tel: +39 02 85464523
Fax: +39 02 85464545
Email: dmengato@eso.net

Alice Ciocchini, aciocchini@eso.net, ph +39 02 85464529


Application by: 30 June 2018  
Save event date: 14 December 2018  




• Age up to 40 years
• At least 2-3 years’ experience in medical or clinical oncology
• Involvement in scientific activities
• Intermediate level of English

Interested oncologists should apply online (at the top of this page) providing:

• Letter describing motivation for attending;
• Supporting letter from head of department or mentor;
• CV with list publications (if the list of publications is not provided, it will be assumed that no articles have been published)
• Clinical case (see below)

Priority will be given to suitable applicants working in Arab and Southern European countries.

Submit an abstract of one page on the template (available at the bottom of this page) describing a clinical case related to one of the subjects of the Masterclass (breast, gynaecological, lung, urological and gastrointestinal cancers). You will have to present your case at the Masterclass in format of a clinical grand round
discussion. Please provide a straightforward a case of your daily clinical practice - no uncommon or extremely rare case. A maximum of 10 slides will be permitted containing:

• Diagnostic considerations
• Treatment
• Results, follow-up
• At least three questions proposed for discussion with the faculty

Participants will be asked to bring their personal laptop or tablet (wireless enabled) to the Masterclass as an event-dedicated website will be created and all questionnaires and certificates will be accessible only from there. Any potential problems with meeting this request should be communicated to the secretariat as part of the application process.

Successful applicants are granted free registration and accommodation

Before you start completing the online application form, please be sure you have all the requested files (CV, Motivation letter, Supporting letter, Professional experience template and Abstract template) ready to be uploaded to the system. Online applications will not be complete unless all the files are uploaded.

Download HERE your Professional experience template
•  Download HERE your Abstract template



13 December

    Participants’ arrival and dinner                     


14 December

7:30   Registration
8:80   Welcome address
Chairs: J. Gligorov, FR - H. Azim, EG
8:30   What the clinician needs to know from the breast pathologist 
G. Pruneri, IT
8:55   Discussion
9:00   Current controversies/challenges in breast surgery
M.J. Cardoso, PT
9:25   Discussion
9:30   The role of radiotherapy in e arly and locally advancedbreast cancer
R. Orecchia, IT
9:55   Discussion
10:00   Coffee break
10:30   Genomic testing in breast cancer
H. Azim jr, LB
10:55   Discussion
11:00   Neoadjuvant/adjuvant chemotherapy and biological agents
G. Curigliano, IT
11:25   Discussion
11:30   Neoadjuvant/adjuvant endocrine therapy
J. Gligorov, FR
11:55   Discussion
12:00   Management of HER2+ advanced breast cancer
G. Curigliano, IT
12:25   Discussion
12:30   Management of triple-negative advanced breast cancer
H. Azim, EG
12:55   Discussion
13:00   Management of ER+ advanced breast cancer
J. Gligorov, FR
13:25   Discussion
13:30   Lunch
14:30   Breast Cancer Tumor Board (4 cases)
Chairs: A. Constantinidou, CY - J.B. Vermorken, BE
15:30   Systemic management of ovarian cancer
J.B. Vermorken, BE
15:55   Discussion
16:00   Systemic management of locally advanced ormetastatic cervical 
and endometrial cancer
J.B. Vermorken, BE
16:25   Discussion
16:30   Coffee break
17:00   Gynecological Cancer Tumor Board (4 cases)


15 December

Chairs: R. Gaafar, EG - F. Geara, LB                
 8:30   The impact of radiation therapy in lung cancer 
F. Geara, LB 
8:55   Discussion
9:00   Neoadjuvant  and adjuvant systemic treatment in NSCLC
G. Ceresoli, IT
9:25   Discussion
9:30   Systemic chemotherapy and targeted treatment in metastatic NSCLC  
J. Remon-Masip, ES
9:55   Discussion
10:00   Immune check point inhibitors in NSCLC
J. Remon-Masip, ES
10:25   Discussion
10:30   Coffee break
  Management of advanced small-cell lung cancer
R. Gaafar, EG                                 
 11:30   Systemic management of advanced mesothelioma
G. Ceresoli, IT
 11:55   Discussion
 12:00   Lung Cancer Tumor Board (4 cases) 
 13:00   Lunch
 14:00   Modern management of melanoma
A. Eggermont, FR
 14:25   Discussion
 14:30   Update  in the management of head and neck cancer 
J.B. Vermorken, BE
 14:55   Discussion
 15:00   How do I manage cancer in elderly patients 
M.S. Aapro, CH
 15:25   Discussion
 15:30   Coffee break
  Parallel Group Sessions I (Cases discussion in three Groups)


16 December

Chairs: H. Khaled, EG - N. Mottet, FR
8:30   Management including active surveillance of localized prostate cancer 
J. Khader, JO
8:55   Discussion
9:05   Key topics in locally advanced, advanced and metastatic prostate cancer
N. Mottet, FR
9:45   Discussion
10:00   Update in the management of bladder cancer
H. Khaled, EG
10:25   Discussion
10:30   Coffee break
11:00   Update in the management of renal cancer
N. Mottet, FR 
11:25   Discussion
11:30   Management of relapsed testicular cancer
A. Shamseddine, LB
12:00   Urological Cancer Tumor Board (4 cases)
13:00   Lunch
 14:00   Supportive care 
M.S. Aapro, CH
 14:25   Discussion
14:30   Update in the management of soft tissue sarcomas
A. Constantinidou, CY
14:55   Discussion                  
15:00   Update in the management of high grade NHL 
A. Stathis, CH
15:25   Discussion
15:30   Coffee break
 16:00   Parallel Group Sessions II (Cases  discussion in three Groups)


17 December

Chairs: D. Papamichael, CY - D. Arnold, PT 
 8:30   Adjuvant / neoadjuvant systemic treatment in colorectal  cancer 
D. Papamichael, CY
8:55   Discussion
 9:00   Systemic treatment in advanced colon cancer
D. Arnold, PT
 9:25   Discussion
 9:30   Radiation treatment in rectal cancer
J. Khader, JO 
9:55   Discussion
10:00   Systemic treatment in early and advanced gastric cancer
D. Arnold, PT
10:25   Discussion
10:30   Coffee break
11:00   Gastrointestinal Cancer Tumor Board (4 cases)
12:00   Learning Self-Assessment Test
13:15   Closing and departures



Follow us